Penta Foundation
Clinical trials sponsored by Penta Foundation, explained in plain language.
-
Could a two-drug pill keep HIV in check for kids?
Disease control OngoingThis study tests whether a two-medicine HIV treatment (dolutegravir and lamivudine) works as well as the usual three-medicine treatment for children aged 2 to 15 who already have their HIV under control. About 386 children will take part, and researchers will check if the simpler…
Phase: PHASE2, PHASE3 • Sponsor: PENTA Foundation • Aim: Disease control
Last updated May 26, 2026 10:41 UTC
-
HIV pill study for kids pulled before it began
Disease control TerminatedThis study aimed to find the right dose of a new HIV pill for children aged 3 and older weighing 22 to 55 pounds. The pill combines two medicines to control HIV. However, the study was withdrawn before any participants were enrolled, so no results are available.
Phase: PHASE1, PHASE2 • Sponsor: PENTA Foundation • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
New hope for kids with drug-resistant HIV: experimental combo shows promise
Disease control OngoingThis study tests a new HIV drug called fostemsavir in children and teens (ages 6 to 17) whose current treatments are no longer working because the virus has become resistant to multiple drugs. The goal is to see if adding fostemsavir to a personalized background therapy can safel…
Phase: PHASE1, PHASE2 • Sponsor: PENTA Foundation • Aim: Disease control
Last updated May 20, 2026 11:57 UTC